Product Description
Mechanisms of Action: N/A
Novel Mechanism: No
Modality: Large Molecule
Route of Administration: N/A
FDA Designation: None *
Approval Status: Not Approved
Approved Countries: None
Approved Indications: None
Known Adverse Events: None
Company: Enzon
Company Location: CRANFORD NJ 07016
Company CEO: Richard L. Feinstein
Additonal Commercial Interests: None
Clinical Description
Countries in Clinic: